Technology company Camgenium launches mobile application aiding individuals battling prostate cancer
Prostate cancer, the most commonly diagnosed cancer in men in the UK, is projected to see a 15% increase in incidence between 2023 and 2040, with approximately 55,000 new cases diagnosed annually [1]. To meet this growing challenge, Camgenium, a software development company, has partnered with Professor Petre Cristian Ilie to develop HealthiumPro, a cloud-based software solution aimed at enhancing pre- and post-surgical care for prostate cancer patients [3].
HealthiumPro is designed to streamline workflows, engage patients, and potentially improve surgical and recovery outcomes in the UK healthcare setting [1]. The system offers a range of features, including digital consent forms, pre-surgery information, access to recommended exercises, appointment information, and remote patient monitoring [2].
The system also includes a centralised stent database to streamline the logging and tracking of stent insertions, a process that is currently not standardised across the NHS, with some hospitals relying on paper-based logging with human oversight [2].
In addition, HealthiumPro assists in the automation of writing surgical notes and correlates surgical data with patient-reported outcomes, providing clinicians with valuable insights to inform decision-making and improve patient care [2].
The HealthiumPro system has been built in compliance with ISO 13485, the regulatory standard for medical devices, and has received regulatory approval to host the system on the NHS private network, HSCN [3]. Camgenium's engineering experts worked closely with Dr. Ilie to understand both patient and hospital clinician needs [2].
Dr. Philip Gaffney, CEO of Camgenium, stated that the company is honoured to have enabled the HealthiumPro system, which has already shown improvements in patient care at hospitals where it has been deployed [3]. He added that Camgenium is ready for nationwide implementation of the HealthiumPro system in other healthcare settings.
Dr. Ilie stated that the partnership with Camgenium is aimed at improving patient safety, outcomes, and efficiencies in the hospital [2]. The system is built on Camgenium's flexible Xenplate platform, a modular, no-code software platform with built-in design tools [2].
With the increase in prostate cancer cases underscoring the need for improved management tools, HealthiumPro represents a significant step forward in the UK's fight against the disease. By leveraging digital technology to streamline workflows, engage patients, and potentially improve surgical and recovery outcomes, HealthiumPro is set to play a crucial role in the future of prostate cancer care in the UK.
References
[1] NHS Digital. (2020). Cancer statistics: Prostate cancer. Retrieved from https://digital.nhs.uk/data-and-information/publications/statistical-work-areas/cancer-statistics/cancer-statistics-prostate-cancer
[2] Camgenium. (2021). HealthiumPro. Retrieved from https://www.camgenium.com/healthiumpro
[3] Camgenium. (2021). Press release: Camgenium and Professor Petre Cristian Ilie partner to develop HealthiumPro, a cloud-based software solution to improve patient safety, outcomes, and efficiencies in the hospital. Retrieved from https://www.camgenium.com/news/camgenium-and-professor-petre-cristian-ilie-partner-to-develop-healthiumpro-a-cloud-based-software-solution-to-improve-patient-safety-outcomes-and-efficiencies-in-the-hospital
- Health tech company, Camgenium, in collaboration with Professor Petre Cristian Ilie, has developed HealthiumPro, a medical device conforming to ISO 13485, aimed at improving patient care and outcomes during pre- and post-surgical care for prostate cancer patients, leveraging digital technology to streamline workflows, engages patients, and potentially improves surgical and recovery outcomes in the UK healthcare setting.
- The HealthiumPro system offers features such as digital consent forms, pre-surgery information, access to recommended exercises, appointment information, remote patient monitoring, a centralised stent database, automation of writing surgical notes, and correlation of surgical data with patient-reported outcomes, providing clinicians with valuable insights to inform decision-making and improve patient care.
- As the incidence of prostate cancer in the UK is predicted to increase by 15% between 2023 and 2040, HealthiumPro represents a significant step forward in the UK's fight against the disease, potentially revolutionising prostate cancer care with its focus on patient safety, outcomes, and efficiencies.
